Dominic Eisinger

Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT.

BioFactura, Inc. develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs. It also specializes in developing and performing in-process and release analytical assays including HPLC methods, SDS-PAGE and Western analysis, antibody/antigen capture ELISAs, and bioactivity methods. The company was founded by Darryl Sampey and Alexandre DeSeabra in 2004 and is headquartered in Frederick, MD.

Multiplex Biosciences, Inc. provides contract multiplex immunoassay development, validation, and manufacturing services to pharmaceutical companies, biotech firms, and academic research institutions. The company is based in Lake Placid, NY. The company was founded by Dominic Eisinger. Multiplex Biosciences was acquired by Myriad RBM, Inc., part of Q2 Solutions from July 01, 2021 on November 15, 2006.